Dysregulation of the NOTCH1 pathway is known in a variety of solid cancers and hematological malignancies, especially in T-cell acute lymphoblastic leukemia (T-ALL) [11,12,13], where the determination of NOTCH1 is already recommended for clinical routine and characterization [1]. This evidence concerns the gene NOTCH1 and hematologic disorder.